You have 9 free searches left this month | for more free features.

TMC114/TMC41629

Showing 1 - 25 of 89

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Healthy Trial in Edegem (DRV/COBI FDC, COBI, DRV)

Completed
  • Healthy
  • DRV/COBI FDC
  • +2 more
  • Edegem, Belgium
    SGS Belgium NV
Oct 25, 2022

HIV-1 Infections Trial in Worldwide (Darunavir, Ritonavir)

Completed
  • HIV-1 Infections
  • Rio De Janeiro, Brazil
  • +16 more
Oct 6, 2022

Human Immunodeficiency Virus (HIV) Trial in South Africa, Spain, United States (DRV/COBI FDC)

Recruiting
  • Human Immunodeficiency Virus (HIV)
  • DRV/COBI FDC
  • Atlanta, Georgia
  • +5 more
Aug 2, 2022

Healthy Trial in Groningen (Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide FDC, Darunavir, Emtricitabine/Tenofovir

Completed
  • Healthy
  • Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide FDC
  • +3 more
  • Groningen, Netherlands
    PRA Health Sciences Onderzoekscentrum Groningen, locatie Martini
Aug 3, 2021

Healthy Trial in Groningen (Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide FDC, Darunavir, Emtricitabine/Tenofovir

Terminated
  • Healthy
  • Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide FDC
  • +3 more
  • Groningen, Netherlands
    PRA Health Sciences Onderzoekscentrum Groningen, locatie Martini
Jul 3, 2020

Antiretroviral Agents in HIV-infected Pregnant Women.

Recruiting
  • HIV Infections
    • Brussels, Belgium
    • +20 more
    Nov 28, 2022

    Virologic Response in Participants Newly Diagnosed With HIV-1

    Completed
    • HIV
    • Antiretroviral Therapy
    • Lisboa, Portugal
      Chlo - Hosp. Egas Moniz
    Jan 17, 2023

    Post-Acute COVID-19 Syndrome Trial in Houston (Stem Cell)

    Not yet recruiting
    • Post-Acute COVID-19 Syndrome
    • Stem Cell
    • Houston, Texas
      The University of Texas Health Science Center at Houston
    Nov 29, 2023

    Tuberous Sclerosis, Lymphangioleiomyomatosis Trial in Canada, United States (procedure, genetic, other)

    Recruiting
    • Tuberous Sclerosis
    • Lymphangioleiomyomatosis
    • Phlebotomy
    • +3 more
    • Birmingham, Alabama
    • +22 more
    Jan 6, 2023

    HIV-1 Infections Trial in Worldwide (Darunavir, Ritonavir)

    Completed
    • HIV-1 Infections
    • Buenos Aires, Argentina
    • +12 more
    Apr 29, 2019

    Healthy Trial in Merksem (Dabigatran Etexilate, DRV/COBI, Ritonavir)

    Completed
    • Healthy
    • Dabigatran Etexilate
    • +3 more
    • Merksem, Belgium
      Clinical Pharmacology Unit
    Jun 8, 2021

    Sickle Cell Disease Trial in Worldwide (Etavopivat Tablets, Placebo Tablets)

    Recruiting
    • Sickle Cell Disease
    • Etavopivat Tablets Low dose
    • +3 more
    • Birmingham, Alabama
    • +77 more
    Oct 11, 2022

    Human Immunodeficiency Virus Trial in Oakland Park (Symtuza)

    Terminated
    • Human Immunodeficiency Virus
    • Oakland Park, Florida
      Midland Research Group, Inc
    Dec 3, 2021

    HIV-1 Trial in Spain, United States (D/C/F/TAF FDC )

    Completed
    • HIV-1
    • D/C/F/TAF FDC placebo
    • Phoenix, Arizona
    • +7 more
    Jul 1, 2021

    Candida Vulvovaginitis Trial in United States (Ibrexafungerp, Placebo)

    Completed
    • Candida Vulvovaginitis
    • Birmingham, Alabama
    • +24 more
    Aug 11, 2021

    External Anogenital Warts Trial in Russian Federation, Ukraine, United States (Podofilox Gel 0.5%, Condylox Topical Gel 0.5%,

    Completed
    • External Anogenital Warts
    • Podofilox Gel 0.5%
    • +2 more
    • Miami, Florida
    • +16 more
    Jul 7, 2021

    Healthy Trial in Fukuoka (Darunavir/Cobicistat)

    Completed
    • Healthy
    • Fukuoka, Japan
      Souseikai Hakata Clinic
    May 15, 2018

    Participants Taking Darunavir/ Cobicistat Plus Emtricitabine and

    Completed
    • Human Immunodeficiency Virus (HIV)
    • D/C/F/TAF Fixed-Dose Combination (FDC)
    • Bergamo, Italy
    • +17 more
    Nov 24, 2020

    Cocaine Dependence Trial in Houston (Citalopram, Placebo)

    Completed
    • Cocaine Dependence
    • Houston, Texas
      UT-Houston Behavioral and Biomedical Sciences Building
    Aug 29, 2020

    Human Immunodeficiency Virus Infection Trial in Sacramento (darunavir with ritonavir and fixed-dose viread+emtricitabine daily)

    Completed
    • Human Immunodeficiency Virus Infection
    • darunavir with ritonavir and fixed-dose viread+emtricitabine daily
    • Sacramento, California
      University of California Davis
    Feb 24, 2020

    Hepatitis B Trial in Worldwide (JNJ-56136379, Placebo, NA (ETV or TDF))

    Completed
    • Hepatitis B
    • Bakersfield, California
    • +75 more
    Oct 24, 2022

    Forehead Rhytides, Forehead Wrinkles Trial in Houston (Botulinum toxin type A, 2.5% lidocaine/2.5% prilocaine, petrolatum

    Completed
    • Forehead Rhytides
    • Forehead Wrinkles
    • Botulinum toxin type A
    • +2 more
    • Houston, Texas
      Robert Cizik Eye Clinic
    Jun 1, 2020

    HIV-1 Trial in United States (DRV/COBI FDC tablet, D/C/F/TAF FDC tablets)

    Completed
    • HIV-1
    • DRV/COBI FDC placebo tablet
    • D/C/F/TAF FDC placebo tablets
    • Phoenix, Arizona
    • +3 more
    May 9, 2019